Single_JJ
strand_NN
conformation_NN
polymorphism_NN
analysis_NN
of_IN
androgen_NN
receptor_NN
gene_NN
mutations_NNS
in_IN
patients_NNS
with_IN
androgen_NN
insensitivity_NN
syndromes_NNS
:_:
application_NN
for_IN
diagnosis_NN
,_,
genetic_JJ
counseling_NN
,_,
and_CC
therapy_NN
._.

Recent_JJ
studies_NNS
indicate_VBP
that_IN
mutations_NNS
in_IN
the_DT
androgen_NN
receptor_NN
gene_NN
are_VBP
associated_VBN
with_IN
androgen_NN
insensitivity_NN
syndromes_NNS
,_,
a_DT
heterogeneous_JJ
group_NN
of_IN
related_JJ
disorders_NNS
involving_VBG
defective_JJ
sexual_JJ
differentiation_NN
in_IN
karyotypic_JJ
males_NNS
._.

In_IN
this_DT
report_NN
,_,
we_PRP
address_VBP
the_DT
possibility_NN
of_IN
rapid_JJ
mutational_JJ
analysis_NN
of_IN
the_DT
androgen_NN
receptor_NN
gene_NN
for_IN
initial_JJ
diagnosis_NN
,_,
genetic_JJ
counseling_NN
,_,
and_CC
molecular_JJ
subclassification_NN
of_IN
affected_VBN
patients_NNS
and_CC
their_PRP$
families_NNS
._.

DNA_NN
from_IN
peripheral_JJ
blood_NN
leukocytes_NNS
of_IN
six_CD
patients_NNS
from_IN
five_CD
families_NNS
with_IN
various_JJ
degrees_NNS
of_IN
androgen_NN
insensitivity_NN
was_VBD
studied_VBN
._.

Exons_NNS
2_CD
to_TO
8_CD
of_IN
the_DT
androgen_NN
receptor_NN
gene_NN
were_VBD
analyzed_VBN
using_VBG
a_DT
combination_NN
of_IN
single_JJ
strand_NN
conformation_NN
polymorphism_NN
analysis_NN
and_CC
direct_JJ
DNA_NN
sequencing_NN
._.

Female_JJ
family_NN
members_NNS
were_VBD
also_RB
studied_VBN
to_TO
identify_VB
heterozygote_NN
carriers_NNS
._.

Point_NN
mutations_NNS
in_IN
the_DT
AR_NN
gene_NN
were_VBD
identified_VBN
in_IN
all_DT
six_CD
patients_NNS
,_,
and_CC
all_DT
mutations_NNS
caused_VBD
amino_NN
acid_NN
substitutions_NNS
._.

One_CD
patient_NN
with_IN
incomplete_JJ
androgen_NN
insensitivity_NN
was_VBD
a_DT
mosaic_NN
for_IN
the_DT
mutation_NN
._.

Four_CD
of_IN
the_DT
five_CD
mothers_NNS
,_,
as_RB
well_RB
as_IN
a_DT
young_JJ
sister_NN
of_IN
one_CD
patient_NN
,_,
were_VBD
carriers_NNS
of_IN
the_DT
mutation_NN
present_JJ
in_IN
the_DT
affected_VBN
child_NN
._.

Our_PRP$
data_NNS
show_VBP
that_IN
new_JJ
mutations_NNS
may_MD
occur_VB
in_IN
the_DT
androgen_NN
receptor_NN
gene_NN
leading_VBG
to_TO
sporadic_JJ
androgen_NN
insensitivity_NN
syndrome_NN
._.

Molecular_JJ
genetic_JJ
characterization_NN
of_IN
the_DT
variant_JJ
allele_NN
can_MD
serve_VB
as_IN
a_DT
primary_JJ
tool_NN
for_IN
diagnosis_NN
and_CC
subsequent_JJ
therapy_NN
,_,
and_CC
can_MD
provide_VB
a_DT
basis_NN
for_IN
distinguishing_VBG
heterozygous_JJ
carriers_NNS
in_IN
familial_JJ
androgen_NN
resistance_NN
._.

The_DT
identification_NN
of_IN
carriers_NNS
is_VBZ
of_IN
substantial_JJ
clinical_JJ
importance_NN
for_IN
genetic_JJ
counseling_NN
._.

